Takeda Pharmaceutical Company Limited

TAKNYSEHealthcare● Active

$15.74

+$0.14(+0.90%)

Market Cap$49.7B

P/E Ratio—

52W High$18.9

52W Low$12.99

Avg Volume3.0M

Open$15.74

Beta0.09

Net Income Financials Revenue

Takeda Pharmaceutical Company Limited (TAK) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

TAK · net income · updated Jun 8, 2026

Core profitability metrics

TAK · net income · margin · TTM · CAGR

Net income was $203.33B for FY2026 (fiscal year ending 2026-03-31), up 88.4% year-over-year. Net profit margin was 4.3%. Based on available data, Takeda Pharmaceutical Company Limited has been profitable since at least 2012.

FY2026 Net Income$203.33B▲ +88.4% YoY

Trailing 12M (TTM)$193.19Btrailing 4 quarters sum

Net Profit Margin4.3%$203.33B ÷ $4.78T

YoY Change+88.4%—

5-Year CAGR-11.6%FY2020 → FY2026

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · TAK net income history · TAK profit margin

Annual net income data

TAK · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2026$203.33B▲ +88.4%4.3%$4.78T

FY2025$107.93B▼ 25.1%2.4%$4.58T

FY2024$144.07B▼ 54.6%3.4%$4.26T

FY2023$317.02B▲ +37.8%7.9%$4.03T

FY2022$230.06B▼ 38.8%6.5%$3.57T

Net income vs peers (Healthcare)

TAK vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Takeda Pharmaceutical Company LimitedYOU

TAK

$203.33B+88.4%4.3%

100%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

10%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Takeda Pharmaceutical Company Limited (TAK) reported net income of $203.33B for FY2026 (fiscal year ending 2026-03-31), up 88.4% year-over-year. The net profit margin was 4.3% — meaning the company kept $0.04 of every dollar of revenue as profit.

Based on available data, Takeda Pharmaceutical Company Limited has been profitable since at least 2012. Net income reached a peak of $376.00B in FY2021. Data available for 15 fiscal years.

Takeda Pharmaceutical Company Limited's net profit margin was 4.3% for FY2026, based on the latest annual results.

Investors sometimes search for "Takeda Pharmaceutical Company Limited net worth" — the company's market capitalization is a separate figure from TAK net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

TAK net income · 5 questions

Takeda Pharmaceutical Company Limited is profitable. The company reported net income of $203.33B for FY2026, a net profit margin of 4.3%. Net income was up 88.4% year-over-year. Based on available data, Takeda Pharmaceutical Company Limited has been profitable since at least 2012.

is TAK profitabledoes TAK make a profitTAK profitabilityTAK profitable company

▸ Source: FMP /income-statement · GAAP · Takeda Pharmaceutical Company Limited · Takeda Pharmaceutical Company Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026